RESEARCH-USE BIOSIMILAR ANTIBODY
Xeligekimab
Monoclonal antibody · IgG4
Xeligekimab (GR 1501) is an anti-human interleukin 17A (IL-17A) humanized monoclonal antibody. Xeligekimab inhibits the pro-inflammatory cascade. Xeligekimab can be used for the research of inflammatory disease, such as radiographic axial spondyloarthritis.
TARGETIL17A
YMonoclonal antibody
CATALOGSC-BS-033
CATALOG NUMBERSC-BS-033
MOLECULAR WEIGHTApprox. 145.66 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Xeligekimab (GR 1501) is an anti-human interleukin 17A (IL-17A) humanized monoclonal antibody. Xeligekimab inhibits the pro-inflammatory cascade. Xeligekimab can be used for the research of inflammatory disease, such as radiographic axial spondyloarthritis.
Xeligekimab is a recombinant research-use antibody directed against IL17A.